Cargando…
Therapeutic targets and signaling pathways of active components of QiLing decoction against castration-resistant prostate cancer based on network pharmacology
QiLing decoction (QLD) is a traditional Chinese medicine compound. This study aims to explore the therapeutic effect of QLD in castration-resistant prostate cancer (CRPC) and its potential bio-targets. A total of 51 active components and QLD 149 targets were identified using bioinformatics analysis....
Autores principales: | Cao, Hongwen, Wang, Dan, Gao, Renjie, Li, Chenggong, Feng, Yigeng, Chen, Lei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
PeerJ Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9245566/ https://www.ncbi.nlm.nih.gov/pubmed/35782093 http://dx.doi.org/10.7717/peerj.13481 |
Ejemplares similares
-
QiLing Decoction promotes ferroptosis of castration-resistant prostate cancer cells by inhibiting FSP1 in vitro and in vivo
por: Cao, Hongwen, et al.
Publicado: (2023) -
Qi Ling decoction enhances abiraterone treatment via suppression of autophagy in castration resistant prostate cancer
por: Feng, Yigeng, et al.
Publicado: (2022) -
Zhoushi Qi Ling decoction represses docetaxel resistance and glycolysis of castration-resistant prostate cancer via regulation of SNHG10/miR-1271-5p/TRIM66 axis
por: Cao, Hongwen, et al.
Publicado: (2021) -
Zhoushi Qiling decoction inhibits proliferation of human prostate cancer cells through IL6/STAT3 pathway
por: Cao, Hongwen, et al.
Publicado: (2023) -
Zhoushi Qiling decoction induces apoptosis of human prostate cancer cells via miR-143/Bcl-2 axis
por: Cao, Hongwen, et al.
Publicado: (2021)